Difficulty: Medium
Average Score: 73%
Practice
A 64-year-old male patient is receiving an aerosol treatment with acetylcysteine and hypertonic saline via a small volume nebulizer. After only a few minutes, the patient suddenly becomes dyspneic. Which of the following is the most likely cause of this problem is?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Bronchospasm. When a patient receiving an aerosol treatment with acetylcysteine and hypertonic saline suddenly becomes dyspneic, bronchospasm is the most likely cause. Acetylcysteine is a mucolytic agent that can irritate the airways and trigger bronchospasm in susceptible individuals.
Option A) Hypercapnia is unlikely in this case as it is characterized by high levels of carbon dioxide in the blood, which would not typically manifest as sudden dyspnea in a short period.
Option C) Hypotension is less likely as the patient's symptoms are more indicative of a respiratory issue rather than a cardiovascular one.
Option D) Fluid overload is also less likely since the patient is receiving aerosolized medications, and dyspnea in this context is more indicative of a respiratory complication like bronchospasm.
Educationally, this question highlights the importance of understanding the potential side effects and adverse reactions associated with respiratory medications. It reinforces the need for healthcare providers to monitor patients closely during treatments and be prepared to manage complications such as bronchospasm promptly and effectively. This knowledge is crucial for safe and effective patient care, especially in respiratory therapy settings.
Option A) Hypercapnia is unlikely in this case as it is characterized by high levels of carbon dioxide in the blood, which would not typically manifest as sudden dyspnea in a short period.
Option C) Hypotension is less likely as the patient's symptoms are more indicative of a respiratory issue rather than a cardiovascular one.
Option D) Fluid overload is also less likely since the patient is receiving aerosolized medications, and dyspnea in this context is more indicative of a respiratory complication like bronchospasm.
Educationally, this question highlights the importance of understanding the potential side effects and adverse reactions associated with respiratory medications. It reinforces the need for healthcare providers to monitor patients closely during treatments and be prepared to manage complications such as bronchospasm promptly and effectively. This knowledge is crucial for safe and effective patient care, especially in respiratory therapy settings.